Off-label use of drugs in children

Pediatrics

Volumn 133, Issue 3, 2014, Pages 563-567

  Neville, Kathleen A ^a   Frattarelli, Daniel A C ^a   Galinkin, Jeffrey L ^a   Green, Thomas P ^a   Johnson, Timothy D ^a   Paul, Ian M ^a   Van Den Anker, John N ^a  

^a NONE

Author keywords

Adolescents; Children; Infants; Off label drug use; Pediatrics; Pharmaceuticals; Prescribing

Indexed keywords

CHILD; DRUG APPROVAL; DRUG INDICATION; FOOD AND DRUG ADMINISTRATION; GOLD STANDARD; HUMAN; INFORMED CONSENT; MEDICAL DECISION MAKING; OFF LABEL DRUG USE; PEDIATRICIAN; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PUBLICATION; RARE DISEASE; SHORT SURVEY;

ADOLESCENTS; CHILDREN; INFANTS; OFF-LABEL DRUG USE; PEDIATRICS; PHARMACEUTICALS; PRESCRIBING;

CHILD; HUMANS; OFF-LABEL USE; PEDIATRICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84895182787     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-4060     Document Type: Short Survey

References (15)

1. American Academy of Pediatrics Committee on Drugs. Uses of drugs not described in the package insert (off-label uses). Pediatrics. 2002;110(1 pt 1):181-183
2. Best Pharmaceuticals for Children Act. Pub L No. 107-109 (2002)
3. Pediatric Research Equity Act. Pub L No. 108-155 (2003)
4. Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161(3):282-290 (Pubitemid 46364332)
5. US Food and Drug Administration. Code of Federal Regulations Title 21. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch. cfm?fr=312.3. Accessed November 20, 2012
6. US Food and Drug Administration. "Off-label" and investigational use of marketed drugs, biologics, and medical devices: information sheet. Available at: http://www.fda.gov/RegulatoryInformation/ Guidances/ucm126486.htm. Accessed January 19, 2014
7. Drug Amendments of 1962. Part A: amendments to assure safety, effectiveness, and reliability. Pub L No. 87-781, x101-308
8. Applications for FDA approval to market a new drug. Adequate and well-controlled studies. (2000) (codified at 21 CFR x314.126)
9. Public Health Service Act. 42 USC x262 (1999)
10. Blazoski v Cook, 346 NJ Super 256, 787 A2d 910 (2002)
11. Shadrick v Coker, 963 SW2d 726, 733 (Tenn 1998)
12. Roberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 2003;290(7):905-911 (Pubitemid 37430462)
13. Steinbrook R. Testing medications in children. N Engl J Med. 2002;347(18):1462-1470 (Pubitemid 35239728)
14. Food and Drug Administration Safety and Innovation Act. Pub L No. 112-144 (2012)
15. Sachs AN, Avant D, Lee CS, Rodriguez W, Murphy MD. Pediatric information in drug product labeling. JAMA. 2012;307(18):1914-1915